10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)

Isabel Syndikus; Clare Griffin; Lara Philipps; Alison Tree; Vincent Khoo; Alison Jane Birtle; Ananya Choudhury; Catherine Ferguson; Joe M. O'Sullivan; Miguel Panades; Yvonne L. Rimmer; Christopher D. Scrase; John Staffurth; Clare Cruickshank; Shama Hassan; Julia Pugh; David P. Dearnaley; Emma Hall

doi:10.1200/jco.2023.41.6_suppl.304

10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)

Isabel Syndikus, Clare Griffin, Lara Philipps, Alison Tree, Vincent Khoo, Alison Jane Birtle, Ananya Choudhury, Catherine Ferguson, Joe M. O'Sullivan, Miguel Panades, Yvonne L. Rimmer, Christopher D. Scrase, John Staffurth, Clare Cruickshank, Shama Hassan, Julia Pugh, David P. Dearnaley, Emma Hall

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	304-304
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	41
Issue number	6_suppl
DOIs	https://doi.org/10.1200/jco.2023.41.6_suppl.304
Publication status	Published - 20 Feb 2023

Keywords

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2023.41.6_suppl.304Licence: Unspecified

Cite this

Syndikus, I., Griffin, C., Philipps, L., Tree, A., Khoo, V., Birtle, A. J., Choudhury, A., Ferguson, C., O'Sullivan, J. M., Panades, M., Rimmer, Y. L., Scrase, C. D., Staffurth, J., Cruickshank, C., Hassan, S., Pugh, J., Dearnaley, D. P., & Hall, E. (2023). 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016). Journal of Clinical Oncology, 41(6_suppl), 304-304. https://doi.org/10.1200/jco.2023.41.6_suppl.304

@article{aedae61abb874386ba36273aed07e5df,

title = "10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)",

keywords = "Cancer Research, Oncology",

author = "Isabel Syndikus and Clare Griffin and Lara Philipps and Alison Tree and Vincent Khoo and Birtle, {Alison Jane} and Ananya Choudhury and Catherine Ferguson and O'Sullivan, {Joe M.} and Miguel Panades and Rimmer, {Yvonne L.} and Scrase, {Christopher D.} and John Staffurth and Clare Cruickshank and Shama Hassan and Julia Pugh and Dearnaley, {David P.} and Emma Hall",

year = "2023",

month = feb,

day = "20",

doi = "10.1200/jco.2023.41.6_suppl.304",

language = "English",

volume = "41",

pages = "304--304",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "6_suppl",

}

Syndikus, I, Griffin, C, Philipps, L, Tree, A, Khoo, V, Birtle, AJ, Choudhury, A, Ferguson, C, O'Sullivan, JM, Panades, M, Rimmer, YL, Scrase, CD, Staffurth, J, Cruickshank, C, Hassan, S, Pugh, J, Dearnaley, DP & Hall, E 2023, '10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)', Journal of Clinical Oncology, vol. 41, no. 6_suppl, pp. 304-304. https://doi.org/10.1200/jco.2023.41.6_suppl.304

10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016). / Syndikus, Isabel; Griffin, Clare; Philipps, Lara et al.

In: Journal of Clinical Oncology, Vol. 41, No. 6_suppl, 20.02.2023, p. 304-304.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)

AU - Syndikus, Isabel

AU - Griffin, Clare

AU - Philipps, Lara

AU - Tree, Alison

AU - Khoo, Vincent

AU - Birtle, Alison Jane

AU - Choudhury, Ananya

AU - Ferguson, Catherine

AU - O'Sullivan, Joe M.

AU - Panades, Miguel

AU - Rimmer, Yvonne L.

AU - Scrase, Christopher D.

AU - Staffurth, John

AU - Cruickshank, Clare

AU - Hassan, Shama

AU - Pugh, Julia

AU - Dearnaley, David P.

AU - Hall, Emma

PY - 2023/2/20

Y1 - 2023/2/20

KW - Cancer Research

KW - Oncology

U2 - 10.1200/jco.2023.41.6_suppl.304

DO - 10.1200/jco.2023.41.6_suppl.304

M3 - Meeting abstract

VL - 41

SP - 304

EP - 304

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 6_suppl

ER -